in-PharmaTechnologist.com presents its weekly round-up of the latest new appoitnments within the world of pharma and biopharma including news from J&J, Teva and Amarantus.
All parties involved in the distribution of biologics in India must take responsibility for quality and keep seasonal temperature variations in mind says the CDSCO.
Menarini has committed millions of euros to an antibody drug conjugate (ADC) clinical development and manufacturing pact with Oxford BioTerapeutics (OBT).
Outsourcing-pharma.com presents a roundup of contract manufacturing news with deals for Lonza, DSM and Ark Therapeutics and an expanded agreement with Shire for AMRI.
Manufacturers trying to prove the similarity of their biosimilars must consider that regulations and reference medicines differ in different markets says Pfizer.
Outsourcing-Pharma.com presents its weekly round-up of the latest appointments in the pharma services industry, including news from Chiltern, Novacep and Emergent.
Thermo Fisher Scientific has set up a unit for molecular biology techs at its site in Lithuania, citing pharmaceutical R&D labs in Eastern Europe as a target.
Agricultural technology firm Monsanto has partnered with Complix NV to develop the latter’s protein therapeutic targeting technology for crop protection applications.
Wuxi AppTec expects to add capacity as needed to service the partnership it formed with MedImmune and is comfortable with the level of investment required.
US CMO Pharmaceutics International (Pii) has been named as the manufacturer of the cranial bleeding treatment voluntarily withdrawn by India’s Sun Pharmaceutical Industries earlier this week.
A new simplified analysis technique of the binding kinetics of membrane proteins could solve a host of drug delivery problems, according to scientists from the Arizona State University.
GE Healthcare has launched an ‘off-the-shelf’ range of modular biomanufacturing facilities that it claims can be designed, constructed and operational in under two years.
